Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function

Simone M. Schoenwaelder(Australian Centre for HIV and Hepatitis Virology Research), Yuping Yuan(Australian Centre for HIV and Hepatitis Virology Research), Emma C. Josefsson(Institute of Molecular Medicine), M. J. D. White(Institute of Molecular Medicine), Yao Yu(Australian Centre for HIV and Hepatitis Virology Research), Kylie D. Mason(Cancer Genetics (United States)), Lorraine A. O’Reilly(Cancer Genetics (United States)), Katya J. Henley(Institute of Molecular Medicine), Akiko Ono(Australian Centre for HIV and Hepatitis Virology Research), Sarah Hsiao(Australian Centre for HIV and Hepatitis Virology Research), Abbey Willcox(Australian Centre for HIV and Hepatitis Virology Research), Andrew W. Roberts(Walter and Eliza Hall Institute of Medical Research), David C.S. Huang(Cancer Genetics (United States)), Hatem H. Salem(Australian Centre for HIV and Hepatitis Virology Research), Benjamin T. Kile(Institute of Molecular Medicine), Shaun P. Jackson(Australian Centre for HIV and Hepatitis Virology Research)
Blood
April 23, 2009
Cited by 309Open Access
Full Text

Abstract

Procoagulant platelets exhibit hallmark features of apoptotic cells, including membrane blebbing, microvesiculation, and phosphatidylserine (PS) exposure. Although platelets possess many well-known apoptotic regulators, their role in regulating the procoagulant function of platelets is unclear. To clarify this, we investigated the consequence of removing the essential mediators of apoptosis, Bak and Bax, or directly inducing apoptosis with the BH3 mimetic compound ABT-737. Treatment of platelets with ABT-737 triggered PS exposure and a marked increase in thrombin generation in vitro. This increase in procoagulant function was Bak/Bax- and caspase-dependent, but it was unaffected by inhibitors of platelet activation or by chelating extracellular calcium. In contrast, agonist-induced platelet procoagulant function was unchanged in Bak(-/-)Bax(-/-) or caspase inhibitor-treated platelets, but it was completely eliminated by extracellular calcium chelators or inhibitors of platelet activation. These studies show the existence of 2 distinct pathways regulating the procoagulant function of platelets.


Related Papers

No related papers found

Powered by citation graph analysis